← Back to headlines
Pulmonx and Beta Bionics Provide 2026 Financial Outlooks
Pulmonx has reiterated its 2026 revenue outlook and gross margin target, while Beta Bionics has outlined its Mint launch timeline and raised its 2026 gross margin outlook. Both companies provided updates on their financial projections.
30 Jul, 06:44 — 30 Jul, 06:44
Sources
Showing 1 of 1 sources
